ContextVision AB (publ) (0L8Z) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Context Vision and welcome to the fourth quarter and full year 2025 report. Today with Richard Hallström, our CFO, myself, Gerald. The transformation of Context Vision is in full swing. So we're combining image quality and data quality into a quantitative imaging business. Our fourth quarter saw early signs of stabilization in the market, but also in our business. We have enrolled our first patient in a clinical study to collect data and test our new data quality products. We have launched a new series of clinical products at RSNA 2025 back in November in Chicago. And if we look to our financial results, the fourth quarter came in at 31.7 million SEC. If we exclude Valuta impacts, this is a minor growth and rolls up to 110.3 million SEC for the year. So quite a positive development in the last quarter that we've seen. Likewise, our margins, 24.9% for the fourth quarter are recovering. If we look to earnings per shares, we closed the year with a black zero, despite changes that we made in our sales and marketing team, and I'll talk to that in a minute. So overall, 2025 has been a demanding year for healthcare and the medical imaging business in general. We mainly saw reduced healthcare budgets, geopolitical uncertainty we talked about in the Q3 webcast, new trade barriers, and a very cautious investment climate. And I think with the Q4 results and the total year results, we show that our business has been resilient despite those difficult market conditions for the year. So let's go a little bit more into the long-term overview of our image quality business which is our ongoing core business if you look to the top line now trailing to 110 million sec rolling 12 for net sales it shows quite resilience over the years with the growth in 2023 and 2024 and then i...